Researchers find alcohol plays no role in disclosing HIV status among Russians

June 11, 2012

Disclosure of HIV positive serostatus to sexual partners is considered an important public health goal to prevent new infections. Disclosure can motivate sex partners to make informed choices and change behavior through negotiation of safer sex practices. It might also prompt partner testing and counseling.

A team of Boston University School of Medicine (BUSM)researchers in cooperation with Pavlov State University investigated nondisclosure of in a cohort of 700 people living with HIV in St. Petersburg, Russia. In Russia, an is currently growing at explosive rates, particularly among . Russians are also worldwide leaders in , which has led to a national health crisis, adds further to health problems and potentially facilitates the spread of HIV.

The BUSM and Pavlov team found that approximately half (52.4 percent) of all participants surveyed reported not having disclosed their HIV serostatus to all partners since they had known of their infection. The study findings, which currently appear on-line in the journal AIDS Behavior, suggest that alcohol seems to play no major role in the decision to disclose or not. However, those in a relationship with a casual partner, an HIV negative partner, or with multiple sex partners were less likely to disclose.

"We now know that nondisclosure of to sex partners is still very common in Russia and that risky alcohol use is also very common however we were there we were unable to detect an association between any alcohol use and the outcome of recent nondisclosure," explained lead author Karsten Lunze, MD, a fellow in the Clinical & Education Unit at BUSM.

According to the authors these results emphasize that Russian health care providers should find out whether their patients have casual, HIV negative, or multiple sex partners, and particularly counsel and encourage those patients to disclose their HIV diagnosis to help prevent a further spread of the dramatic HIV epidemic in Russia.

Explore further: Study finds HIV-infected men at risk for spreading HIV despite taking HAART

Related Stories

Study finds HIV-infected men at risk for spreading HIV despite taking HAART

March 27, 2012
Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in the semen of sexually active HIV-infected men ...

Fighting HIV in South Africa should focus on couples, study finds

April 25, 2011
A new study of sexual risk behaviors within long-term couples in South Africa finds that HIV-positive people take almost as much risk in their sexual behavior when they know their partner is HIV-negative or don't know their ...

Researchers find CDT biomarker ineffective for identifying unhealthy alcohol use

June 20, 2011
Researchers from Boston University School of Medicine (BUSM) have found that among HIV-infected adults with alcohol problems, measuring their carbohydrate-deficient transferrin (CDT) biomarker was a poor and inaccurate method ...

Recommended for you

Three-in-one antibody protects monkeys from HIV-like virus

September 20, 2017
A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

Fighting HIV on multiple fronts might lead to vaccine

September 20, 2017
A combination antibody strategy could be the key to halting the spread of HIV, according to results from two promising animal studies.

HIV-AIDS: Following your gut

September 18, 2017
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have discovered a way to slow viral replication in the gastrointestinal tract of people infected by HIV-AIDS.

Study finds cutbacks in foreign aid for HIV treatment would cause great harm

August 30, 2017
Proposed reductions in U.S. foreign aid would have a devastating impact on HIV treatment and prevention programs in countries receiving such aid, an international team of investigators reports. In their paper published online ...

Cancer drug can reactivate HIV

August 24, 2017
People living with HIV must take a combination of three or more different drugs every day for the rest of their lives. Unfortunately, by following this strict treatment plan, they can suffer from side effects ranging from ...

New injectable antiretroviral treatment proved to be as effective as standard oral therapy

August 3, 2017
Intramuscularly administered antiretroviral therapy (ART) may be as effective for HIV treatment as current oral therapies. This is the main conclusion of a Phase II clinical trial carried out by 50 research centers around ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.